These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29122448)

  • 21. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
    Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.
    Looker HC; Colombo M; Hess S; Brosnan MJ; Farran B; Dalton RN; Wong MC; Turner C; Palmer CN; Nogoceke E; Groop L; Salomaa V; Dunger DB; Agakov F; McKeigue PM; Colhoun HM;
    Kidney Int; 2015 Oct; 88(4):888-96. PubMed ID: 26200946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and Kidney Injury in Diabetic African American Men.
    Cao L; Boston A; Jegede O; Newman HA; Harrison SH; Newman RH; Ongeri EM
    J Diabetes Res; 2019; 2019():5359635. PubMed ID: 30868076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):359-366. PubMed ID: 32075807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
    Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
    J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.
    Bian X; Griffin TP; Zhu X; Islam MN; Conley SM; Eirin A; Tang H; O'Shea PM; Palmer AK; McCoy RG; Herrmann SM; Mehta RA; Woollard JR; Rule AD; Kirkland JL; Tchkonia T; Textor SC; Griffin MD; Lerman LO; Hickson LJ
    BMJ Open Diabetes Res Care; 2019; 7(1):e000720. PubMed ID: 31908790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
    Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
    Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
    Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang SF; Subramaniam T; Sum CF; Lim SC
    Nephrology (Carlton); 2019 Oct; 24(10):1026-1032. PubMed ID: 30565819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients.
    Asao T; Oki K; Yoneda M; Tanaka J; Kohno N
    Endocr J; 2016; 63(2):119-26. PubMed ID: 26537094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year renal function trajectory and its association with adverse renal event in patients with type 2 diabetes.
    Li TC; Yu TY; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Chiang JH; Lin CC
    J Diabetes Complications; 2018 Aug; 32(8):784-790. PubMed ID: 29895439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.
    Bhatraju PK; Zelnick LR; Shlipak M; Katz R; Kestenbaum B
    J Am Soc Nephrol; 2018 Nov; 29(11):2713-2721. PubMed ID: 30287518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: Evidence from northeastern Thailand.
    Zaman SB; Karim MA; Hossain N; Al Kibria GM; Islam SMS
    Diabetes Res Clin Pract; 2018 Apr; 138():238-245. PubMed ID: 29448006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function.
    Kim WJ; Kim SS; Bae MJ; Yi YS; Jeon YK; Kim BH; Song SH; Kim IJ; Kim YK
    J Diabetes Complications; 2014; 28(2):130-4. PubMed ID: 24438886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.